Virus (2) Basic elements

Similar documents
Influenza viruses. Virion. Genome. Genes and proteins. Viruses and hosts. Diseases. Distinctive characteristics

Influenza virus.

INFLUENZA VIRUS. Influenza virus

Evolutionary distances between proteins of the Influenza A Virus

Antiviral Drugs Lecture 5

INFLUENZA VIRUS. INFLUENZA VIRUS CDC WEBSITE

Antiviral Chemotherapy

- They come in all sizes. -- General Structure is similar.

Antiviral Agents I. Tutorial 6

Flu, Avian Flu and emerging aspects (H1N1 resistance)

Viral reproductive cycle

Antiviral Chemotherapy


Pandemic Influenza influenza epidemic: realization of a worst-case scenario

Human Influenza. Dr. Sina Soleimani. Human Viral Vaccine Quality Control 89/2/29. November 2, 2011 HVVQC ١

Structure of viruses

Influenza virus.

Medical Virology. Herpesviruses, Orthomyxoviruses, and Retro virus. - Herpesviruses Structure & Composition: Herpesviruses

Cover Page. The handle holds various files of this Leiden University dissertation

Avian Influenza: Armageddon or Hype? Bryan E. Bledsoe, DO, FACEP The George Washington University Medical Center

ORTHOMYXOVIRUSES INFLUENZA VIRUSES. (A,B and C)

Influenza Infection In Human. Dr. Zuhaida A. Jalil Surveillance Sector Disease Control Division, MOH Malaysia 3 May 2018

Coronaviruses cause acute, mild upper respiratory infection (common cold).

Evolution of influenza

Orthomyxoviridae and Paramyxoviridae. Lecture in Microbiology for medical and dental medical students

Q: If antibody to the NA and HA are protective, why do we continually get epidemics & pandemics of flu?

Steps in viral replication (I)

STRUCTURE, GENERAL CHARACTERISTICS AND REPRODUCTION OF VIRUSES

Current Vaccines: Progress & Challenges. Influenza Vaccine what are the challenges?

Antiviral Agents DEPARTEMEN FARMAKOLOGI & TERAPEUTIK FK USU. 06 August

HS-LS4-4 Construct an explanation based on evidence for how natural selection leads to adaptation of populations.

Overview: Chapter 19 Viruses: A Borrowed Life

Respiratory Viruses. Respiratory Syncytial Virus

VIROLOGY OF INFLUENZA. Subtypes: A - Causes outbreak B - Causes outbreaks C - Does not cause outbreaks

MONTGOMERY COUNTY COMMUNITY COLLEGE CHAPTER 13: VIRUSES. 1. Obligate intracellular parasites that multiply in living host cells

Protein Modeling Event

INFLUENZA-1. VL 6 Dec. 8 th Mohammed El-Khateeb

INFLUENZA VIRUS. Influenza virus

Viral Diseases. Question: 5/17/2011

دکتر بهروز نقیلی استاد بیماریهای عفونی مرکس تحقیقات بیماریهای عفونی و گرمسیری پاییس 88

11/15/2011. Outline. Structural Features and Characteristics. The Good the Bad and the Ugly. Viral Genomes. Structural Features and Characteristics

19 Viruses BIOLOGY. Outline. Structural Features and Characteristics. The Good the Bad and the Ugly. Structural Features and Characteristics

Lecture Guide Viruses (CH13)

LESSON 1.4 WORKBOOK. Viral structures. Just how small are viruses? Workbook Lesson 1.4 1

Influenza: A seasonal disease FACTFILE

Unit 2: Lesson 2 Case Studies: Influenza and HIV LESSON QUESTIONS

Treatment of respiratory virus infection Influenza A & B Respiratory Syncytial Virus (RSV)

LESSON 4.4 WORKBOOK. How viruses make us sick: Viral Replication

Ralph KY Lee Honorary Secretary HKIOEH

Influenza: Seasonal, Avian, and Otherwise

LESSON 1.4 WORKBOOK. Viral sizes and structures. Workbook Lesson 1.4

AP Biology. Viral diseases Polio. Chapter 18. Smallpox. Influenza: 1918 epidemic. Emerging viruses. A sense of size

Nothing to disclose. Influenza Update. Influenza Biology. Influenza Biology. Influenza A 12/15/2014

Swine Flu, Fiction or Reality

Influenza. Paul K. S. Chan Department of Microbiology The Chinese University of Hong Kong

Influenza: The past, the present, the (future) pandemic

Some living things are made of ONE cell, and are called. Other organisms are composed of many cells, and are called. (SEE PAGE 6)

Biology 350: Microbial Diversity

numbe r Done by Corrected by Doctor

The "Flu" a case of low fever and sniffles that keeps you home in bed for a day a gastrointestinal upset ("stomach flu")

Oseltamivir (Tamiflu ) for Acute Influenza. John Collins Spring 2014 BME 270

Patricia Fitzgerald-Bocarsly

Lecture 19 Evolution and human health

Human Immunodeficiency Virus. Acquired Immune Deficiency Syndrome AIDS

Introduction to viruses. BIO 370 Ramos

Diagnosing and managing

Influenza 2009: Not Yet The Perfect Storm

Coronaviruses. Virion. Genome. Genes and proteins. Viruses and hosts. Diseases. Distinctive characteristics

Part I. Content: History of Viruses. General properties of viruses. Viral structure. Viral classifications. Virus-like agents.

Antiviral Drugs. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018

Antiviral Drugs. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018

*viruses have no cell wall and made up of nucleic acid components.

Treatment of Influenza. Dr. YU Wai Cho

INFLUENZA. By :Nader Alaridah MD, PhD

1918 Influenza; Influenza A, H1N1. Basic agent information. Section I- Infectious Agent. Section II- Dissemination

Overview of the Influenza Virus

Influenza surveillance and pandemic preparedness - a global challenge Anne Kelso

7.013 Spring 2005 Problem Set 7

Antivirals. Lecture 20 Biology 3310/4310 Virology Spring 2017

History electron microscopes

INFLUENZA-2 Avian Influenza

INFLUENZA A VIRUS. Structure of the influenza A virus particle.

Novel H1N1 Influenza. It s the flu after all! William Muth M.D. Samaritan Health Services 9 November 2009

Acute respiratory illness This is a disease that typically affects the airways in the nose and throat (the upper respiratory tract).

Influenza A 6/23/2010. Lisa Winston, MD UCSF / San Francisco General Hospital Divisions of Infectious Diseases and Hospital Medicine

Outline. Seasonal Influenza & Pneumonia National & State Statistics Novel Influenza A H1N1

Lecture 2: Virology. I. Background

PHARMACEUTICAL MICROBIOLOGY JIGAR SHAH INSTITUTE OF PHARMACY NIRMA UNIVERSITY

VIRUSES. 1. Describe the structure of a virus by completing the following chart.

Fayth K. Yoshimura, Ph.D. September 7, of 7 HIV - BASIC PROPERTIES

LESSON 4.5 WORKBOOK. How do viruses adapt Antigenic shift and drift and the flu pandemic

Influenza. Tim Uyeki MD, MPH, MPP, FAAP

Should the U.S. develop and stockpile vaccines against A(H5N1) avian flu?

Modeling the Antigenic Evolution of Influenza Viruses from Sequences

Influenza: The Threat of a Pandemic

Phylogenetic Methods

Tamiflu. Tamiflu (oseltamivir) Description

HSV DNA replication. Herpesvirus Latency. Latency and Chemotherapy. Human Herpesviruses - subtypes. Acyclovir (acycloguanosine) {Zovirax}

Human Immunodeficiency Virus

LECTURE OUTLINE. B. AGENT: Varicella-zoster virus. Human herpes virus 3. DNA virus.

Transcription:

Virus (2) Basic elements Structure of DNA and RNA: base = contains information phosphate = linker, charged gives solubility desoxyribose = 2 nd linker, gives helical structure nucleotide = basic element http://ici.cegep-ste-foy.qc.ca/profs/gbourbonnais/pascal/nya/genetique/notesadn/adn3.htm Double stranded b-dna helix : Virus (6) Basic elements minor groove major groove http://ici.cegep-ste-foy.qc.ca/profs/gbourbonnais/pascal/nya/genetique/notesadn/adn3.htm -1- -2- Prénom NomUniversité de Neuchâtel -1- Prénom Nom / 12/01/2010

Double stranded DNA helix : Virus (7) Basic elements http://ici.cegep-ste-foy.qc.ca/profs/gbourbonnais/pascal/nya/genetique/notesadn/adn3.htm Conformational Analysis (1) DNA is constructed of the following elements: 4 different heterocyclic bases A, G, T, C 1 sugar desoxyribose 1 phosphate DNA is a double stranded helix DNA is the molecule for information storage = permanent memory = exclusive function -3- -4- Prénom NomUniversité de Neuchâtel -2- Prénom Nom / 12/01/2010

Conformational Analysis (2) RNA is constructed of the following elements: 4 different heterocyclic bases A, G, U, C 1 sugar ribose 1 phosphate RNA is often single stranded with multiple structures and multiple functions RNA is the molecule for information transcription = active memory; structural unit = reading head; catalytic activity = functional unit Conformational Analysis (3) DNA is resistant to chemical hydrolysis = stable for years RNA is sensitive to chemical hydrolysis = degrades within minutes Reasons: internal nucleophile steric congestion DNA RNA -5- -6- Prénom NomUniversité de Neuchâtel -3- Prénom Nom / 12/01/2010

Conformational Analysis (4) RNA hydrolysis is helped by the presence of the additional H group Conformational Analysis (5) Homo-DNA contains 1 CH2 group more = homologous to DNA Therefore homo-dna contains a six-membered ring instead of a five-membered ring. This makes the conformational analysis much easier. DNA Homo-DNA -7- -8- Prénom NomUniversité de Neuchâtel -4- Prénom Nom / 12/01/2010

Conformational Analysis (5 bis) Synthesis of homo-dna and conformational analysis done by: Prof, Albert Eschenmoser (ETH-Z and Scripps) Homo-DNA Conformational Analysis (6) Three levels Diamond lattice -9- -10- Prénom NomUniversité de Neuchâtel -5- Prénom Nom / 12/01/2010

Conformational Analysis (7) Introduction of an idealized conformation of Homo-DNA-trinucleotide into a diamond lattice Conformational Analysis (8) Repetitive structure of DNA characterized by δ = 60 Gives an almost linear double strand -11- -12- Prénom NomUniversité de Neuchâtel -6- Prénom Nom / 12/01/2010

Conformational Analysis (9) Homo-DNA: δ = 60 DNA: δ > 60 ; δ(max) = 120 Conformational Analysis (10) DNA: δ ~ 80 The skeleton of the single strand is helical The helicity is fixed by the double strand formation (= base pair formation) -13- -14- Prénom NomUniversité de Neuchâtel -7- Prénom Nom / 12/01/2010

Virus (10) Structure of the Influenza Virus Figure 1: Transmission electron micrograph of avian influenza H5N1 virus Figure 2: Influenza Virus Anatomy STRUCTURE The structure of the influenza virus (see Figure 2) is somewhat variable, but the virion particles are usually spherical or ovoid in shape and 80 to 120 nanometers in diameter. http://www.sfcdcp.org/index.cfm?id=87 http://micro.magnet.fsu.edu/cells/viruses/influenzavirus.html Virus (11) Structure of the Influenza Virus Trimeric hemagglutinin Schematic representation STRUCTURE The influenza virion is an enveloped virus that derives its lipid bilayer from the plasma membrane of a host cell. Two different varieties of glycoprotein spike are embedded in the envelope. Approximately 80 percent of the spikes are hemagglutinin, a trimeric protein that functions in the attachment of the virus to a host cell. The remaining 20 percent of the glycoprotein spikes consist of neuraminidase, which is thought to be predominantly involved in facilitating the release of newly produced virus particles from the host cell. http://micro.magnet.fsu.edu/cells/viruses/influenzavirus.html -15- -16- Prénom NomUniversité de Neuchâtel -8- Prénom Nom / 12/01/2010

Virus (12) Structure of the Influenza Virus Electron microscopic pictures of the influence virus Electron microscopic picture showing the helical ribonucleo-protein STRUCTURE n the inner side of the envelope that surrounds an influenza virion is an antigenic matrix protein lining. Within the envelope is the influenza genome, which is organized into eight pieces of single-stranded RNA (A and B forms only; influenza C has 7 RNA segments). The RNA is packaged with nucleoprotein into a helical ribonucleoprotein form, with three polymerase peptides for each RNA segment. http://web.uct.ac.za/depts/mmi/stannard/fluvirus.html Virus (13) Structure of the Influenza Virus Life cycle of the influence virus STRUCTURE Specific varieties of the virus are generally named according to the particular antigenic determinants of hemagglutinin (13 major types) and neuraminidase (9 major types) surface proteins they possess, as in influenza A(H2N1) and A(H3N2). New strains of the influenza virus emerge due to a gradual process known as antigenic drift. Through this mechanism, the virus is able to largely circumvent the body's immune system. http://micro.magnet.fsu.edu/cells/viruses/influenzavirus.html -17- -18- Prénom NomUniversité de Neuchâtel -9- Prénom Nom / 12/01/2010

Virus (14) Classification and Nomenclature of Influenza Virus CLASSIFICATIN of virus STRAINS Is done on the basis of antigenicity of NP (nucleoprotein) and MP (matrix protein) into three main groups: Influenza A -HA undergoes minor and occasional major changes - very important. - NA some variation. Influenza B) Undergoes relatively slow change in HA with time. Known only in man. Influenza C) Uncommon strain, known only in man. NMENCLATURE Influenza strains are named in the following way: A TYPE of influenza SINGAPRE TWN where first isolated 6 NUMBER of isolates 86 YEAR of isolation (H1N1) MAJR TYPE of HA and NA http://micro.magnet.fsu.edu/cells/viruses/influenzavirus.html Virus (15) Epidemiology Influenza A virus is essentially an avian virus that has "recently" crossed into mammals. Birds have the greatest number and range of influenza strains. Avian haemagglutinins sometimes appear in pig human and horse influenza strains. Every now and then (10-15 years) a major new pandemic strain appears in man, with a totally new HA and sometimes a new NA as well (antigenic shift). This variant causes a major epidemic around the world (pandemic). ver the subsequent years this strain undergoes minor changes (antigenic drift) every two to three years, probably driven by selective antibody pressure in the populations of humans infected. http://micro.magnet.fsu.edu/cells/viruses/influenzavirus.html -19- -20- Prénom NomUniversité de Neuchâtel -10- Prénom Nom / 12/01/2010

Influenza A Evolution Virus (16) Epidemiology 1874 --- (H3N8) 1890 --- (H2N2)...Pandemic 1902 --- (H3N2) 1918 --- (H1N1)...Pandemic 1933 --- (H1N1)...First strains isolated 1947 --- (H1N1)...Variation detected 1957 --- (H2N2)..."Asian" Flu pandemic 1968 --- (H3N2)..."Hong Kong" Flu pandemic 1976 --- (H1N1)..."Swine" Flu, non-epidemic 1977 --- (H1N1) + (H3N2)..."Russian" Flu epidemic http://micro.magnet.fsu.edu/cells/viruses/influenzavirus.html Virus (17) Anti-Viral Chemotherapy Stages in virus replication which are possible targets for chemotherapeutic agents: Attachment to host cell Uncoating - (Amantadine) Synthesis of viral mrna - (Interferon) Translation of mrna - (Interferon) Replication of viral RNA or DNA - (Nucleoside anologues) Maturation of new virus proteins (Protease inhibitors) Budding, release Diseases for which effective therapy is available: Herpes Simplex virus (Acyclovir) Varicella-Zoster virus (Acyclovir) Cytomegalovirus (Gancyclovir, Foscarnet) AIDS (Zidovudine, Lamivudine[3TC], Protease inhibitors; in combination) Respiratory Syncitial virus (Ribavirin) Influenza (Amantadine) http://web.uct.ac.za/depts/mmi/jmoodie/welcome1.html -21- -22- Prénom NomUniversité de Neuchâtel -11- Prénom Nom / 12/01/2010

Virus (18) Anti-Viral Chemotherapy Nucleotide analogues: These are synthetic compounds which resemble nucleosides, but have an incomplete or abnormal deoxy-ribose /or ribose group.these compounds are phosphorylated to the tri-phosphate form within the infected cell. In this form, the drug competes with normal nucleotides for incorporation into viral DNA or RNA. http://web.uct.ac.za/depts/mmi/jmoodie/welcome1.html Virus (19) Treatment and Prophylaxis of Influenzavirus Zanamivir (Relenza) 1 st neuramidase inhibitor Sialic acid The release of sialic acid is inhibited by compounds like Zanamivir or seltamivir 1999 The drugs, Relenza and Tamiflu, are licensed in US and Europe. http://web.uct.ac.za/depts/mmi/stannard/fluvirus.html -23- -24- Prénom NomUniversité de Neuchâtel -12- Prénom Nom / 12/01/2010

http://www.biozentrum.unibas.ch/~schwede/teaching/bixii-ss05/boehm_i.pdf http://www.biozentrum.unibas.ch/~schwede/teaching/bixii-ss05/boehm_i.pdf -25- -26- Prénom NomUniversité de Neuchâtel -13- Prénom Nom / 12/01/2010

http://www.biozentrum.unibas.ch/~schwede/teaching/bixii-ss05/boehm_i.pdf Neuramidase X-ray structure from Swiss Protein Data bank Tetramer Asymetric Unit Swiss Protein Data Bank: Accession NumberQ8JT58 (http://www.expasy.org/uniprot/q8jt58) The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor Varghese, J.N., McKimm-Breschkin, J.L., Caldwell, J.B., Kortt, A.A., Colman, P.M. Proteins v14 pp. 327-32, 1992-27- -28- Prénom NomUniversité de Neuchâtel -14- Prénom Nom / 12/01/2010

Neuramidase X-ray structure from Swiss Protein Data bank Q8JT58 X-ray structure of Neuraminidase with a transition state analog inhibitor http://www.biozentrum.unibas.ch/~schwede/teaching/bixii-ss05/boehm_i.pdf -29- -30- Prénom NomUniversité de Neuchâtel -15- Prénom Nom / 12/01/2010

X-ray structure of Neuraminidase with Zanamivir http://www.biozentrum.unibas.ch/~schwede/teaching/bixii-ss05/boehm_i.pdf Comparison of the binding the transition state analog and seltamivir (Tamiflu) http://www.biozentrum.unibas.ch/~schwede/teaching/bixii-ss05/boehm_i.pdf -31- -32- Prénom NomUniversité de Neuchâtel -16- Prénom Nom / 12/01/2010

Tamiflu (1) Source: Coopération Tamiflu (2) Significant reduction in flu duration: Multicenter, double-blind, randomized and placebo-controlled studies of 253 otherwise healthy adults aged 18 to 65 years with naturally acquired influenza. Significant reduction in the duration of fever: Multicenter, double-blind, randomized and placebo-controlled studies (one in the U.S. and two outside of the U.S.) of 610 otherwise healthy adults aged 18 to 65 years with naturally acquired influenza. Tamiflu home page: http://www.tamiflu.com/hcp/treatment/treat_index.asp -33- -34- Prénom NomUniversité de Neuchâtel -17- Prénom Nom / 12/01/2010

Tamiflu (3) Reduction in viral shedding in challenge studies: Challenge studies support A antiviral activity in volunteers who received TAMIFLU or placebo shortly after influenza virus inoculation. Reduction in viral shedding in challenge studies : Challenge studies support B antiviral activity in volunteers who received TAMIFLU or placebo shortly after influenza virus inoculation. Tamiflu home page: http://www.tamiflu.com/hcp/treatment/treat_index.asp Synthesis of Tamiflu Phosphate d oseltamivir (R) N H (R) (S) NH 2. H 3 P 4-36- (3R,4R,5S)-4-Acetylamino-5-amino-3-(1-ethylpropoxy)-1- cyclohexene-1-carboxylic acid ethyl ester -35- Prénom NomUniversité de Neuchâtel -18- Prénom Nom / 12/01/2010

Synthesis : General Scheme (1) H CH 1) EtH, SCl 2 (0,5 eq) reflux, 3h 2) Evaporation H CEt 1) 3-pentanone (25 eq), TsH (0,05 eq) 2) Extraction 3) Evaporation CEt H 97% H 97% H H H 1 2 3 1) MsCl (1,3 eq) 2) Et 3N (2,0 eq), CH 2Cl 2, 0-5 C 3) Extraction 93% 1) KHC 3, EtH CEt H 2, 60 C 2) Evaporation 3) Extraction à l'hexane 1) BH CEt. 3 SMe 2, CH 2Cl 2 TMSTf, -20 C 2) Addition lente de NaHC 3 CEt 6 60 % de 4 H 5 Ms 4 Ms Synthesis : General Scheme (2) 1) NH 2 CEt MgBr 2.Et 2 (0,2 eq) t-bume / MeCN 9:1 55 C, 16h 2) (NH 4) 2S 4 / H 2 1) Pd/C, EtH CEt H 2NCH 2H reflux, 3h 2) H 2S 4 / H 2 CEt 97% 77% H H HN 6 7 8 NH 2 1) PhCH, t-bume, - H 2 2) MsCl, NEt 3, filtration 80% NH 3) 2, 112 C, 15h 4) HCl/H 2 CEt 1) 10% Pd/C, EtH H 2NCH 2CH 2H reflux, 3h 2) H 3P 4, EtH CEt Ac 2, AcH MsH t-bume, 15h, 20 C CEt HN 70 % HN 83% H 2N NH 2. H 3P 4 HN HN 11 10 9-37- -38- Prénom NomUniversité de Neuchâtel -19- Prénom Nom / 12/01/2010

Synthesis : General Scheme (1) Synthesis : General Scheme (2) -39- -40- Prénom NomUniversité de Neuchâtel -20- Prénom Nom / 12/01/2010

Natural Source of Shikimic acid: Star Anise The characteristically shaped fruits (pods), always used in dried state. The dried fruits may contain 5 to 8% of essential oil, which dominated by anethole (85 to 90%). The other components, phellandrene, safrole and terpineol, have only small effect on the aroma. Corey s Synthesis (2006) -41- -42- Prénom NomUniversité de Neuchâtel -21- Prénom Nom / 12/01/2010

Characteristics of the commercial product Sold as gelatinized capsule or as solution For anti-viral treatment, can beusedfor preventionof flu Inhibits neuraminidase. Reduces the capacity of the propagation of the virus «Commercial History» seltamivir sold by Gilead Sciences for 80 millions CHF and 10% in royalties, commercialised under the name of Tamiflu by Roche Estimated sells for 2005 : 1,12 billion CHF, 55 millions packages sold, corresponds to 3,3% of the total sells of Roche Estimated sells: 150 millions packages for 2006 and 300 millions for 2007-43- -44- Prénom NomUniversité de Neuchâtel -22- Prénom Nom / 12/01/2010

Sources J. rg. Chem. 2001, 66, 2044-2051 J. rg. Chem., 1998, 63,4545-4550 J. Am. Chem. Soc, 2006, 128, 6310-6311 rg. Process Res. Dev. 1999, 3, 266 Wikipedia -45- Prénom NomUniversité de Neuchâtel -23- Prénom Nom / 12/01/2010